| P2093 | author name string | Nathan C | |
| | Rolland Y | |
| P2860 | cites work | Effect of zimelidine, a new antidepressant, on appetite and body weight | Q34448847 |
| | A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) | Q35177369 |
| | Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding | Q39099247 |
| | The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine | Q40313063 |
| | Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa | Q48597684 |
| | Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain. | Q53736779 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 277-296 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Pharmacological treatments that affect CNS activity: serotonin | |
| P478 | volume | 499 | |